GHO Capital snaps up Genesis Research in latest pharma services bet

The health outcomes research (HEOR) and Real-World Evidence research organization joins GHO's growing umbrella of pharma services companies taking a transatlantic strategy.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this